Dermaliq is a series a startup based in United States. 2 investors tracked on Brouky Intelligence. Status: zombie. Data sourced from Brouky Intelligence.
About
Dermaliq is a clinical-stage dermatology company developing novel topical therapies for common skin diseases using its proprietary water-free drug delivery platform, hyliQ.
Stage
series-a
Investors
2
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky